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The  efficacy  of  a  novel  topical  combination  formulation  of  fipronil,  (S)-methoprene,  epri-
nomectin  and praziquantel  against  naturally  acquired  intestinal  nematode  and  cestode
infections  in  cats  was  evaluated  in  seven  negative  control,  blinded  studies.  Cats  were
selected  based  on  a pre-treatment  faecal  examination  indicating  a  patent  infection  with
at least  hookworms  (two  studies),  Toxocara  ascarids  (one  study),  taeniid  cestodes  (two
studies)  or Dipylidium  cestodes  (two  studies).  In  each  study,  cats  were assigned  randomly
to blocks  of two animals  each,  based  on  decreasing  pre-treatment  body  weight  and  were
randomly  allocated  to one  of  two  groups  of six to 12 cats: untreated  (control)  or treated
with  topical  fipronil  (8.3%,  w/v),  (S)-methoprene  (10%, w/v),  eprinomectin  (0.4%,  w/v)
and  praziquantel  (8.3%,  w/v)  (BROADLINE®, Merial)  at 0.12  mL/kg  body  weight  (providing
a  minimum  of  10  mg fipronil  + 12  mg  S-methoprene  +  0.5 mg  eprinomectin  + 10 mg  prazi-
quantel  per kg  body  weight).  The  topical  treatment  was  administered  directly  on  the  skin
in the  midline  of the neck  in a single  spot once  on Day  0.  For  parasite  recovery  and  count,
cats  were euthanized  humanely  and  necropsied  seven  or ten  days  after  treatment.  A  sin-
gle treatment  with  the  novel  topical  combination  product  provided  91%  efficacy  against
Ancylostoma  braziliense,  ≥99%  efficacy  against  Ancylostoma  tubaeforme,  and  >97%  efficacy
against  Toxocara  cati.  Similarly,  excellent  efficacy  was  established  against  Taenia  taeniae-
formis, Dipylidium  caninum  and  Diplopylidium  spp.  as  demonstrated  by  >97%  and  up  to
100%  reductions  of  cestode  counts  in  the treated  cats  when  compared  to the  untreated
controls  (P  <  0.01).  All cats  accepted  the treatment  well based  on  health  observations  post-
treatment  and daily  health  observations.  No  adverse  experiences  or other  health  problems
were observed  throughout  the studies.  The  results  of  this  series  of  controlled  studies
demonstrated  high  effica
formulation  of  fipronil,  (S
range  of feline  intestinal  n
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. Introduction
Cats can harbour a wide variety of internal parasites.
espite an increase in prophylactic use of anthelmintics
nd increasing awareness of protozoan parasites in the
ast two decades, helminths still are recognized as being
idespread and important parasites of cats. This preva-
ence is true not only for cats of high risk populations, such
s stray feral cats or cats from rescue shelters (e.g., Miró
t al., 2004; Robben et al., 2004; Ingstrup, 2008; Palmer
t al., 2008; Gracenea et al., 2009; Duarte et al., 2010;
adczuk and Balicka-Ramisz, 2010; Claerebout et al., 2011;
offe et al., 2011; Lucio-Forster and Bowman, 2011; Becker
t al., 2012; Blagburn et al., 2012), but also for pets (e.g.,
oati et al., 2003; Palmer et al., 2008; Gates and Nolan,
009; Ładczuk and Balicka-Ramisz, 2010; Barutzki and
chaper, 2011; Claerebout et al., 2011; Joffe et al., 2011;
toh et al., 2012; Mugnaini et al., 2012; Näreaho et al., 2012).
ecause of access to the outdoors, even pet cats are at risk
f being infected with gastrointestinal helminths, which
ay  be diagnosed more often in cats from rural areas than
n those from urban environments (Coati et al., 2003; Miró
t al., 2004; Mircean et al., 2010; Capári et al., 2013).
The most prevalent helminth parasites of domestic cats
re ascarid and ancylostomatid nematodes and taeniid
nd dipylidiid tapeworms. Toxocara cati is the most com-
on  nematode parasite of the gastrointestinal tract of cats
hroughout the world. Ancylostoma hookworms are the
econd most common nematodes of cats with two  main
pecies. While Ancylostoma tubaeforme is a cosmopoli-
an parasite of cats, Ancylostoma braziliense has a more
estricted distribution and occurs in both cats and dogs
n Africa and North and South America. Taenia taeniae-
ormis and Dipylidium caninum are by far the most prevalent
apeworms found in cats and have a worldwide distribu-
ion. Other species of cestodes which parasitize cats have a
ore restricted geographic distribution, such as Echinococ-
us multilocularis or Diplopylidium and Joyeuxiella species,
r have been recorded incidentally only, e.g., T. crassiceps,
. hydatigena or T. pisiformis (Stoichev et al., 1982; Wilson-
anson and Prescott, 1982; Bowman et al., 2002; Takács
nd Takács, 2002; Schuster et al., 2009).
The novel topical formulation Broadline®1 (Merial)
s a broad spectrum product combining the acari-
ide/insecticide fipronil and the insect growth regulator
S)-methoprene with two well-known anthelmintics,
he macrocyclic lactone, eprinomectin, and praziquan-
el, a quinoline derivative. While topical fipronil and
S)-methoprene combinations or topical formulations con-
aining praziquantel have been available for several years
or the treatment of feline parasites, the anthelmintic prop-
rties of eprinomectin in cats are described for the first time
n these studies. The studies reported here were designed
o evaluate the efficacy and acceptability of the novel
opical combination when administered to cats harbou-
ing naturally acquired intestinal nematode and/or cestode
nfections.
1 Broadline® is a trademark of Merial; all other marks are the property
f  their respective owners.tology 202 (2014) 18–25 19
2. Materials and methods
The design of the studies was  in accordance with the
International Cooperation on Harmonisation of Techni-
cal Requirements for Registration of Veterinary Medicinal
Products (VICH) – GL7, “Efficacy of Anthelmintics: Gen-
eral Requirements” (Vercruysse et al., 2001), VICH GL20
“Efficacy of Anthelmintics: Specific Recommendations
for Felines” (Vercruysse et al., 2002), and the “World
Association for the Advancement of Veterinary Parasito-
logy (WAAVP) guidelines for evaluating the efficacy of
anthelmintics for dogs and cats” (Jacobs et al., 1994). All
studies were conducted in compliance with VICH GL9, enti-
tled Good Clinical Practice and in compliance with local
animal welfare legislation and were approved by an Inde-
pendent Animal Care and Use Committee. All personnel
involved in collecting efficacy data were blinded to the
treatment assignment of the animals.
2.1. Experimental animals
The seven studies were conducted in the Republic
of South Africa (Studies 1 and 4), Albania (Studies 2, 3
and 6), Qatar (Study 5), and Mexico (Study 7). A total
of 138 (71 male, 67 female) domestic short-haired cats,
owned by the respective contract research organization,
weighing between 0.7 and 4.56 kg prior to treatment, and
aged approximately three months to seven years at the
time of treatment, were included (details are presented
in Table 1). The animals were housed individually during
the entire studies and acclimated to the study facilities
for at least seven days prior to treatment. The environ-
mental conditions were identical for all animals within a
study.
2.2. Selection of animals based on pre-treatment faecal
examination
The selection criterion for inclusion of cats was the
documented presence of a patent infection with specific
target parasites, i.e., hookworms (two studies), Toxocara
ascarids (one study), taeniid cestodes (two studies), or
Dipylidium cestodes (two studies), as confirmed by exam-
ination of faecal samples collected during the acclimation
period.
Faecal samples collected during the acclimation period
were processed similarly in all studies. First, faeces were
examined visually and macroscopically for the presence of
cestode proglottids. Samples were then tested for nema-
tode and cestode eggs using modified McMaster techniques
to establish faecal nematode egg counts (Studies 1–6)
or a double centrifugation/sucrose floatation technique
(Study 7). Solutions used for floatation (zinc sulphate solu-
tion adjusted to a specific gravity of 1.3, four studies;
Sheater’s sucrose solution, three studies), amount of faeces
processed (1 g or 4 g of faeces, one study each; 2 g of faeces,
five studies) and the sensitivity of counting techniques (1
egg ≡ 25 eggs per g [EPG], three studies; 1 egg ≡ 50 EPG, one
study; 1 egg ≡ 67 EPG, two studies) varied between sites.
Parasites were identified based on the distinct morphol-
ogy of their faecal forms, and results were reported as eggs
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Table 1
Characteristics of experimental animals and results of pre-treatment faecal examination.
Study/group Sexa Approximate
age (range)
Pre-treatmentb
body weight (kg)
Pre-treatmentc faecal
examination
Dipylidiid
(evidenced)
Taeniid
(evidence)
Hookworm
(EPGe, range)
Toxocara (EPG,
range)
Study 1 – target parasite: Ancylostoma braziliense
Untreated 6 M,  4 F 4
months–adult
1.4–3.3 4/10 3/10 800–3600 0
Treatedf 7 M,  3 F 5
months–adult
1.4–3.0 1/10 5/10 933–4867 0
Study  2 – target parasite: Ancylostoma tubaeforme
Untreated 5 M,  5 F 4 months–7
years
0.9–3.3 4/10 0/10 100–800 0–1000
Treatedf 5 M,  5 F 5 months–7
years
0.9–3.3 3/10 0/10 50–700 0–20,050
Study  3 – target parasite: Toxocara cati
Untreated 4 M,  6 F 3 months–4
years
0.9–2.6 6/10 0/10 0–8250 50–4750
Treatedf 2 M,  8 F 3 months–4
years
0.7–3.6 6/10 0/10 0–1000 100–2050
Study  4 – target parasite: Taenia taeniaeformis
Untreated 6 M,  5 F 4 months–3
years
1.3–3.2 0/11 11/11 0–667 0–1200
Treatedf 3 M,  8 F 5 months–2
years
1.1–3.0 0/11 11/11 0–2600 0
Study  5 – target parasite: Taenia taeniaeformis
Untreated 8 M,  4 F 7 months–3
years
1.2–4.6 5/12 12/12 0–100 0
Treatedf 11 M,  1 F 8 months–3
years
1.5–4.5 3/12 12/12 0–500 0–100
Study  6 – target parasite: Dipylidium caninum
Untreated 5 M,  5 F 7 months–4
years
1.2–3.6 10/10 0/10 0–18,600 0–1150
Treatedf 6 M,  4 F 8 months–3
years
1.5–3.1 10/10 0/10 0–1250 0–8450
Study  7 – target parasite: Dipylidium caninum
Untreated 2 M,  4 F 1.5 years–4
years
2.3–3.9 6/6 0/6 2/6d 1/6d
Treatedf 1 M,  5 F 8 months–4
years
2.2–3.6 6/6 0/6 0/6d 1/6d
a M,  male; F, female.
b Day-3, Day-2 or Day-1 prior to treatment (=Day 0).
c Day-6 or Day-5 prior to treatment (=Day 0).
d
ectin (0Number of positive cats/number of cats in group.
e EPG, eggs per gram of faeces.
f Broadline® = fipronil (8.3%, w/v), (S)-methoprene (10%, w/v), eprinom
per gram for each nematode and presence/absence of ces-
tode proglottids/eggs (Studies 1–6) or presence/absence of
nematode eggs and cestode proglottids/eggs (Study 7). All
cats included were shown to harbour at least hookworm
(Studies 1 and 2), Toxocara (Study 3), taeniid cestode (Stud-
ies 4 and 5) or dipylidiid cestode (Studies 6 and 7) infections
(Table 1). Apart from the target parasite for each study,
faecal examinations also showed evidence of co-infections
with various other gastrointestinal helminths in many cats,
as shown in Table 1.2.3. Experimental design
The studies were conducted under a similar protocol
utilizing a randomized block design. Replicates of two cats.4%, w/v) and praziquantel (8.3%, w/v) at 0.12 mL/kg body weight.
each were formed sequentially, based on decreasing pre-
treatment body weights. Within replicates, animals were
allocated randomly to one of two  groups: untreated control
group or treated group.
The treatment (fipronil (8.3%, w/v), (S)-methoprene
(10%, w/v), eprinomectin (0.4%, w/v) and praziquantel
(8.3%, w/v)) was  administered topically at the min-
imum therapeutic dose of 0.12 mL/kg body weight
(providing a minimum of 10 mg  fipronil + 12 mg (S)-
methoprene + 0.5 mg  eprinomectin + 10 mg  praziquantel
per kg body weight) directly on the skin in the midline
of the neck, between the base of the skull and the shoul-
der blades, in a single spot once on Day 0. All cats were
observed for health problems and adverse events hourly for
four hours post-treatment and thereafter once daily until
the end of the study.
y Parasitology 202 (2014) 18–25 21
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across studies (Table 4).
In Study 5, 100% efficacy was demonstrated against the
cestode Diplopylidium spp. Based on the minimum numberM. Knaus et al. / Veterinar
All study animals were euthanized humanely and
ecropsied to obtain a total gastrointestinal helminth count
even days (Studies 1, 2, 3, 6, 7) or ten days (Studies 4 and
) after treatment.
.4. Parasite recovery and count
The contents of the whole gastrointestinal tract (stom-
ch, small and large intestines) were collected. To facilitate
he isolation and counting of helminths, organ contents
ere washed through appropriately sized sieves to
emove debris. Counts of parasites were made on total
astrointestinal contents. Helminths were identified to
pecies/genus, if possible, according to their morphology.
.5. Data analysis
Parasite counts for the target parasite in each individ-
al study were transformed to the natural logarithm of
count + 1) for calculation of geometric means for each
reatment group. Efficacy for the topically treated group
as calculated as the percent efficacy using the formula
00 × [(C − T)/C], were C is the geometric mean among
ntreated controls and T is the geometric mean among the
reated animals. The log-counts of the treated group were
ompared to the log-counts of the untreated control group
sing a F-test adjusted for the allocation blocks. The Mixed
rocedure in SAS® Version 9.1.3 was used for this analysis
ith group as the fixed effect and allocation blocks as the
andom effect. Testing was two-sided at the significance
evel  ˛ = 0.05.
In addition to the analysis of target parasite counts,
ounts of helminth species which occurred as co-infections
ith target parasites in one study only (A. braziliense and
iplopylidium spp. in Studies 4 or 5, respectively) were
nalyzed as described before. Species which occurred as co-
nfection with target parasites in more than one study were
ncluded in a combined analysis per parasite as follows: A.
ubaeforme, Studies 1, 3, 4, 5, 6 and 7; T. cati, Studies 2, 4, 6
nd 7; T. taeniaeformis,  Studies 1, 3 and 7; D. caninum, Stud-
es 1, 2, 3 and 4. Overall efficacy was calculated as percent
eduction in worm counts as 100[(C − T)/C], were C is the
eometric mean among untreated controls and T is the geo-
etric mean among the treated animals treated. Helminth
ounts were analyzed using the Van Elteren rank test with
ndividual studies considered to be blocks for this com-
ined analysis. The PROC MIXED procedure in SAS, version
.1.3 was used with group as a fixed effect and individual
tudy as the random effect. A two-tailed significance level
f 0.05 was used for all tests.
. Results
No adverse events or other health problems were
bserved throughout the studies, indicating that the topical
reatment was well accepted. No medications other than
he investigational product were administered.Identification of helminth parasites recovered from the
astrointestinal tract of the cats revealed the presence
f nematodes (A. braziliense,  Studies 1 and 4; A. tubae-
orme, Studies 1–7; T. cati, Studies 2, 3, 4, 6, 7), cestodesFig. 1. Scolex of Diplopylidium spp. (© Merial).
(D. caninum, Studies 1, 2, 3, 4, 6, 7; Diplopylidium spp., Study
5, Figs. 1 and 2; T. taeniaeformis,  Studies 1, 3, 4, 5, 7) and one
trematode (Echinoparyphium spp., Study 1) (Table 2).
The studies met  the recommendations as to adequacy-
of-infection as specified by VICH GL7 and VICH GL20,
because at least six cats in each untreated (control) group
harboured the minimum number of parasites of the tar-
get species accepted as adequate, i.e. 10 A. braziliense, 20 A.
tubaeforme,  5 T. cati, 4 T. taeniaeformis,  and 2 D. caninum.
The results of the seven studies as regards the target
parasites are summarized in Table 3. Cats treated with
the combination product had significantly (P < 0.01) fewer
adult A. braziliense,  A. tubaeforme, T. cati, T. taeniaeformis
and D. caninum than the untreated controls with a reduc-
tion of the worm burden ranging from ≥91% to 100%.
Analysis of data of the nematode and cestode para-
sites occurring as co-infection with the target parasites
revealed efficacies of 90.7% and 100% against A. braziliense
and Diplopylidium spp., respectively, and overall efficacies
of >97% for all other species in the analysis of pooled dataFig. 2. Mature proglottid of Diplopylidium spp. (© Merial).
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Table 2
Parasites recovered from the gastrointestinal tract of the study animals following necropsy seven (Studies 1, 2, 3, 6 and 7) or ten days (Studies 4 and 5)
after  treatment.
Study/group Number of cats infected/number of cats in group (range of counts)
Ancylostoma
braziliense
Ancylostoma
tubaeforme
Toxocara cati Dipylidium
caninum
Diplopylidium
spp.
Taenia
taeniaeformis
Echinoparyphium
spp.
Study 1 – target parasite: Ancylostoma braziliense
Untreated 10/10 (10–114) 5/10 (0–27) 0/10 4/10 (0–63) 0/10 7/10 (0–19) 1/10 (1)
Treateda 6/10 (0–25) 0/10 0/10 0/10 0/10 0/10 1/10 (123)
Study 2 – target parasite: Ancylostoma tubaeforme
Untreated 0/10 10/10 (2–71) 5/10 (0–37) 8/10 (0–75) 0/10 0/10 0/10
Treateda 0/10 2/10 (0–2) 1/10 (0–1) 2/10 (0–1) 0/10 0/10 0/10
Study  3 – target parasite: Toxocara cati
Untreated 0/10 5/10 (0–34) 10/10 (1–16) 8/10 (0–140) 0/10 1/10 (0–1) 0/10
Treateda 0/10 0/10 1/10 (0–1) 1/10 (0–2) 0/10 0/10 0/10
Study  4 – target parasite: Taenia taeniaeformis
Untreated 8/11 (0–53) 5/11 (0–1) 3/11 (0–11) 5/11 (0–21) 0/11 11/11 (1–26) 0/11
Treateda 3/11 (0–2) 1/11 (1) 0/11 0/11 0/11 0/11 0/11
Study  5 – target parasite: Taenia taeniaeformis
Untreated 0/12 7/12 (0–56) 0/12 0/12 8/12 (0–130) 10/12 (0–44) 0/12
Treateda 0/12 0/12 0/12 0/12 0/12 2/12 (0–1) 0/12
Study  6 – target parasite: Dipylidium caninum
Untreated 0/10 7/10 (0–33) 3/10 (0–5) 8/10 (0–181) 0/10 0/10 0/10
Treateda 0/10 0/10 0/10 1/10 (0–2) 0/10 0/10 0/10
Study  7 – target parasite: Dipylidium caninum
Untreated 0/6 1/6 (1) 2/6 (0–2) 6/6 (10–279) 0/6 3/6 (0–6) 0/6
a 1/6 (0
 dose [fiTreated 0/6 0/6 0/6 
a Treated = Broadline® spot on for cat applied at minimum therapeutic
and  praziquantel (8.3%, w/v) at 0.12 mL/kg body weight].
of two parasites accepted as an adequate infection for the
other dipylidiid cestode, eight of the 12 untreated control
animals were adequately infected with cestodes in Study
5. Thus, this study was considered to meet the sense of
adequacy-of-infection as specified by VICH GL7 and VICH
GL20 for Diplopylidium spp.
4. Discussion
Apart from the echinostome trematodes found in two
cats from South Africa, the helminths recovered from the
gastrointestinal tract of the untreated control animals are
common parasites of cats, and the occurrence of all para-
sites has been documented previously in the countries
Table 3
Parasite counts and therapeutic efficacy in cats of Broadline® against naturally ac
Parasite Study Untreated 
NI/NGd GMe (range) 
Ancylostoma braziliense 1 10/10 31.30 (10–114)  
Ancylostoma tubaeforme 2 10/10 19.01 (2–71)  
Toxocara cati 3 10/10 5.14 (1–16) 
Taenia  taeniaeformis 4 11/11 6.40 (1–26) 
5  10/12 8.30 (0–44)  
Dipylidium caninum 6 8/10 13.68 (0–181)  
7  6/6 54.90 (10–279)  
a Treated = Broadline® spot on for cat applied at minimum therapeutic dose [fi
and  praziquantel (8.3%, w/v) at 0.12 mL/kg body weight].
b Efficacy = 100 [(geometric mean untreated (control) − geometric mean Topica
c Two-sided P-value comparing the worm burden of the Topical FMEP group w
d NI/NG: Number of cats Infected/Number of cats in Group.
e Geometric mean parasite count (based on transformation to ln [count + 1]).–142) 0/6 0/6 0/6
pronil (8.3%, w/v), (S)-methoprene (10%, w/v), eprinomectin (0.4%, w/v)
where the studies were conducted (Flores-Barroeta, 1955;
Baker et al., 1989; King et al., 2006; Abu-Madi et al., 2007,
2010; Knaus et al., 2011, 2012).
Results of the current series of studies which targeted
three nematodes and two  cestodes of cats demonstrate that
Broadline® is highly effective against naturally acquired
infections of those feline parasites. Although partly based
on relatively low levels of infection, analyses of the data for
parasites occurring in co-infection with the target parasites
demonstrated statistically significant difference between
the counts of treated and untreated control animals. The
analysis of the overall observations of effects of topical
fipronil, (S)-methoprene, eprinomectin and praziquantel
against these parasites is therefore considered conclusive
quired intestinal nematode and cestode parasites – target parasites.
Treateda Efficacy (%)b P-valuec
NI/NG GM (Range)
6/10 2.80 (0–25)  91.0 0.002
2/10 0.20 (0–2)  99.0 <0.001
1/10 0.07 (0–1)  98.6 <0.001
0/11 0 100 <0.001
2/10 0.10 (0–1)  98.5 <0.001
1/10 0.12 (0–2)  99.2 0.001
1/6 1.30 (0–142) 97.7 0.008
pronil (8.3%, w/v), (S)-methoprene (10%, w/v), eprinomectin (0.4%, w/v)
l FMEP)/geometric mean untreated (control)].
ith the untreated (control) group.
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Table  4
Parasite counts and therapeutic efficacy in cats of Broadline® against naturally acquired intestinal nematode and cestode parasites – analysis of species
which  occurred as co-infection with the target parasite.
Parasite Occurring in study/studies Untreated Treateda Efficacy (%)d P-value
NI/TNb GMc (range) NI/TN GM (range)
Ancylostoma braziliense 4 8/11 3.22 (0–53)  3/11 0.30 (0–2) 90.7 0.014e
Ancylostoma tubaeforme 1, 3, 4, 5, 6, 7 30/59 1.31 (0–56)  1/59 0.01 (0–1) 99.1 <0.001f
Toxocara cati 2, 4, 6, 7 13/37 0.64 (0–37)  1/37 0.02 (0–1) 97.1 <0.001f
Taenia taeniaeformis 1, 3, 7 11/26 0.91 (0–19) 0/26 0 100 <0.001f
Dipylidium caninum 1, 2, 3, 4 25/41 3.78 (0–140) 3/41 0.08 (0–2) 97.9 <0.001f
Diplopylidium spp. 5 8/12 6.00 (0–130) 0/12 0 100 0.0039e
a Treated = Broadline® spot on for cat applied at minimum therapeutic dose [fipronil (8.3%, w/v), (S)-methoprene (10%, w/v), eprinomectin (0.4%, w/v)
and  praziquantel (8.3%, w/v) at 0.12 mL/kg body weight].
b NI/NG: number of cats infected/total number of cats.
c Geometric mean parasite count (based on transformation to ln [count + 1]).
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ed Efficacy = 100 [(geometric mean untreated (control) − geometric mea
e Two-sided P-value comparing the worm burden of the Topical FMEP 
f Probability from Van Elteren rank test.
nd provides additional evidence of the efficacy of the new
ombination product against A. braziliense,  A. tubaeforme,
. cati, D. caninum and T. taeniaeformis.
The macrocyclic lactone eprinomectin was developed
nd registered originally as a topical formulation for use in
attle at a dosage of 0.5 mg  per kg body weight with indi-
ations against a broad range of both external and internal
arasites, including common nematodes of the gastroin-
estinal tract and lungworms (Shoop and Soll, 2002).
he bioavailability of eprinomectin following the topical
dministration of the novel fipronil, (S)-methoprene, epri-
omectin and praziquantel combination to cats as spot-on
s similar to that following the pour-on administration of
he 0.5% (w/v) eprinomectin solution (EPRINEX® Pour-On,
erial) to cattle (Kvaternik et al., 2014). The efficacy of
prinomectin at 0.5 mg  per kg body weight administered
s a single spot directly onto the skin of cats in the novel
opical fipronil, (S)-methoprene, eprinomectin and prazi-
uantel combination against feline hookworm and ascarid
nfections demonstrated in the present studies is compara-
le to results noted in studies which assessed the efficacy
f eprinomectin administered topically at the same dosage
o cattle infected with bovine hookworms and ascarids
Avcioglu and Balkaya, 2011; Rehbein et al., 2012).
Praziquantel has been used for the treatment of feline
apeworm infections for many years with oral, injectable
nd spot-on formulations available for use in cats against
nfections with T. taeniaeformis,  E. multilocularis and D.
aninum (Dey-Hazra, 1976; Gürlap et al., 1976; Rommel
t al., 1976; Bauditz and Sachs, 1979; Oakley, 1991; Jenkins
nd Romig, 2000). Beside the worldwide distributed D.
aninum, cestodes of the other two genera belonging to
he same family of tapeworms (Dipylidiidae), Diplopylid-
um and Joyeuxiella,  have a more restricted distribution
mainly Mediterranean basin, Middle East, Middle Asia)
nd their heteroxenous life-cycle with domestic and wild
anids and felids serving as definitive hosts is partly
nknown (Schuster et al., 2009). In Europe, Diplopylidium
nd/or Joyeuxiella species are observed in cats in Alba-
ia, Bulgaria, France, Greece, Italy, Portugal and Spain (e.g.,
aralampides, 1978; Stoichev et al., 1982; Dorchies et al.,
990; Calvete et al., 1998; Porqueddu et al., 2004; Knaus
t al., 2011, 2012; Waap et al., 2013). Apart from providingl FMEP)/geometric mean untreated (control)].
ith the untreated (control) group.
consistently high efficacy against D. caninum, praziquantel
administered at 5 mg  per kg body weight was  reported to
be highly effective against another dipylidiid tapeworm
in cats, J. pasqualei (Gürlap et al., 1976; Dorchies et al.,
1990). However, there is also one case report describing the
successful removal of a Joyeuxiella infection from a cat fol-
lowing subcutaneous injection of praziquantel at 25 mg  per
kg body weight only while the administration of injectable
praziquantel at 5 mg  per kg body weight did not remove
all parasites (Schuster and Montag, 2000). In one study of
the current series presented here, for the first time, praz-
iquantel was demonstrated to provide excellent efficacy
against Diplopylidium.  Since D. caninum, Diplopylidium and
Joyeuxiella species are closely related, praziquantel may
thus be the compound of choice for the treatment of the
structurally similar dipylidiid cestodes in cats.
Results of the current series of studies, as well as
other controlled laboratory studies including cats with
induced nematode (Knaus et al., 2014; Prullage et al., 2014)
and E. multilocularis infections (Tielemans et al., 2014)
demonstrate that Broadline® (fipronil, (S)-methoprene,
eprinomectin and praziquantel) is highly effective in
cats against naturally acquired and induced infections of
adult gastrointestinal nematodes and cestodes. In addi-
tion, results of this series of controlled studies have been
confirmed in a multicenter field study conducted in seven
countries of Europe where cats treated with the novel spot-
on combination showed >99.9% and 100% faecal egg count
reductions for Toxocara and hookworms, respectively, and
had no evidence of taeniid and Dipylidium infections after
treatment (Rehbein et al., 2014).
Conflict of interest
The work reported herein was funded by Merial Limited,
GA, USA. All authors are current employees or contractors
of Merial.Acknowledgments
The authors gratefully acknowledge Lenaïg Halos and
Frédéric Beugnet for the editorial review of the manuscript.
y Parasi24 M. Knaus et al. / Veterinar
References
Abu-Madi, M.A., Behnke, J.M., Prabhaker, K.S., Al-Ibrahim, R., Lewis, J.W.,
2010. Intestinal helminths of feral cat populations from urban and
suburban districts of Qatar. Vet. Parasitol. 168, 284–292.
Abu-Madi, M.A., Pal, P., Al-Thani, A., Lewis, J.W., 2007. Descriptive epi-
demiology of intestinal helminth parasites from stray cat populations
in Qatar. J. Helminthol. 81, 1–11.
Avcioglu, H., Balkaya, I., 2011. Efficacy of eprinomectin against Toxocara
vitulorum in calves. Trop. Anim. Health Prod. 43, 283–286.
Baker, M.K., Lange, L., Verster, A., Plaat, S.V.D., 1989. A survey of helminths
in  domestic cats in the Pretoria area of Transvaal, Part 1: The preva-
lence and comparison of burdens of helminths in adult and juvenile
cats. J. S. Afr. Vet. Assoc. 60, 139–142.
Barutzki, D., Schaper, R., 2011. Results of parasitological examinations of
faecal samples from cats and dogs in Germany between 2003 and
2010. Parasitol. Res. 109 (Suppl. 1), S45–S60.
Bauditz, R., Sachs, H., 1979. Droncit® injectable: new possibilities of tape-
worm control. Vet. Med. Rev. 2, 129–133.
Becker, A.-C., Rohen, M., Epe, C., Schnieder, T., 2012. Prevalence of
endoparasites in stray and fostered dogs and cats in Northern
Germany. Parasitol. Res. 111, 849–857.
Blagburn, B.L., Little, S.E., Butler, J.M., Land, T.M., Mount, J.D., Wright, J.C.,
Griffin, B., Hostetler, J., 2012. National prevalence of parasites in shel-
ter cats based on centrifugal fecal flotation. In: 57th Ann. Meet. Am.
Ass. Vet. Parasitol., 04–07 August 2012, San Diego, CA, USA, p. 77,
Abstract.
Bowman, D.D., Hendrix, C.H., Lindsay, D.S., Barr, S.C., 2002. Feline Clinical
Parasitology. Iowa State Univ. Press, Ames, Iowa.
Calvete, C., Lucientes, J., Castello, J.A., Estrada, R., Gracia, M.J., Peribán˜ez,
M.A.,  Ferrer, M., 1998. Gastrointestinal helminth parasites in stray cats
from the mid-Ebro valley, Spain. Vet. Parasitol. 75, 235–240.
Capári, B., Hamel, D., Visser, M.,  Winter, R., Pfister, K., Rehbein, S., 2013.
Parasitic infections of domestic cats, Felis catus, in western Hungary.
Vet. Parasitol. 192, 33–42.
Claerebout, E., De Wilde, N., Sarre, C., Van Weyenberg, M.,  Vercruysse,
J.,  2011. Intestinal parasites in different cat populations in northern
Belgium. In: Proc. 23rd Int. Conf. World Assoc. Adv. Vet. Parasitol.,
21–25 August 2011, Buenos Aires, Argentina, p. 218.
Coati, N., Hellmann, K., Mencke, N., Epe, C., 2003. Recent investigation on
the prevalence of gastrointestinal nematodes in cats from France and
Germany. Parasitol. Res. 90 (Suppl. 3), S146–S147.
Dey-Hazra, A., 1976. The efficacy of Droncit® (Praziquantel) against tape-
worm infections in dog and cat. Vet. Med. Rev. 2, 134–141.
Dorchies, P., Franc, M.,  Ducos de Lahitte, J., Berthonneau, M.C., 1990. Traite-
ment du teniasis du chien et du chat par le praziquantel. Rev. Méd. Vét.
131, 409–411.
Duarte, A., Castro, I., Pereira da Fonseca, I.M., Almeida, V., Madeira
de  Carvalho, L.M., Meireles, J., Fazendeiro, M.I., Tavares, L., Vaz,
Y.,  2010. Survey of infectious and parasitic diseases in stray cats
at  the Lisbon Metropolitan Area, Portugal. J. Feline Med. Surg. 12,
441–446.
Flores-Barroeta, L., 1955. Helmintos de los perros Canis familiaris y gatos
Felis catus en el la Ciudad de México. An. Esc. Nac. Cienc. Biol. 8,
159–202.
Gates, M.C., Nolan, T.J., 2009. Endoparasite prevalence and recurrence
across different age groups of dogs and cats. Vet. Parasitol. 166,
153–158.
Gracenea, M.,  Soledad Gómez, M.,  Torres, J., 2009. Prevalence of intesti-
nal parasites in shelter dogs and cats in the metropolitan area of
Barcelona. Acta Parasitol. 54, 73–77.
Gürlap, N., Tig˘in, Y., Og˘uz, T., Tinar, R., Burgu, A., 1976. Preliminary studies
on  the effect of Droncit® against different tapeworms in dogs and cats.
Vet. Med. Rev. 2, 129–133.
Haralampides, S.T., 1978. Contribution to the study of cat’s para-
sites and their public health importance. Hell. Vet. Med. 21,
117–119.
Ingstrup, A., 2008. Parasitter hos danske katte – en prævalensundersøgelse
af 719 internatkatte. Hovedopgave ved Fagdyrlægekursus i syg-
domme  hos hund & kat, Copenhagen, available at www.ddd.dk/../
2009-01%20Astrid%20Ingstrup.pdf (accessed 24.02.12).
Itoh, N., Ikegami, H., Takagi, M.,  Ito, Y., Kanai, K., Chikazawa, S., Hori,
Y., Hoshi, F., Higuchi, S., 2012. Prevalence of intestinal parasites in
private-household cats in Japan. J. Feline Med. Surg. 14, 436–439.Jacobs, D.E., Arakawa, A., Courtney, C.H., Gemmell, M.A., McCall, J.W.,
Myers, G.H., Vanparijs, O., 1994. World Association for the Advance-
ment of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating
the efficacy of anthelmintics for dogs and cats. Vet. Parasitol. 52,
179–202.tology 202 (2014) 18–25
Jenkins, D.J., Romig, T., 2000. Efficacy of Droncit® Spot-on (praziquantel)
4% (w/v) against immature and mature Echinococcus multilocularis in
cats. Int. J. Parasitol. 30, 959–962.
Joffe, D., Niekerk, D., Gagné, v., Gilleard, F., Kutz, J., Lobingier, S.R., 2011. The
prevalence of intestinal parasites in dogs and cats in Calgary, Alberta.
Can. Vet. J. 52, 1323–1328.
King, P.H., Kok, D.J., Baker, C., 2006. Echinostome parasites in cats in the
Fauresmith district, Free State. J. S. Afr. Vet. Assoc. 77, 101–102.
Knaus, M., Kusi, I., Rapti, D., Xhaxhiu, D., Winter, R., Visser, M.,  Rehbein, S.,
2011. Endoparasites of cats from the Tirana area and the first report
on Aelurostrongylus abstrusus (Railliet, 1898) in Albania. Wien. Klin.
Wochenschr. 123 (Suppl. 1), 31–35.
Knaus, M.,  Postoli, R., Rapti, D., Xhaxhiu, D., Visser, M., Winter, R., Dim-
itrova, Z., Rehbein, S., 2012. Helminthen bei Katzen aus dem Großraum
Tirana. In: Tagung Dtsch. Vet. Med. Ges., Fachgr. Parasitol., 02–04 July
2012, Hannover, Germany, p. 22, Abstract.
Knaus, M.,  Baker, C.F., Reinemeyer, C.R., Chester, T.S., Rosentel, J., Rehbein,
S., 2014. Efficacy of a novel topical combination of fipronil, (S)-
methoprene, eprinomectin and praziquantel against adult and larval
stages of Toxocara cati in cats. Vet. Parasitol. 202, 34–39.
Kvaternik, V., Kellermann, M.,  Knaus, M.,  Rehbein, S., Rosentel, J.,
2014. Pharmacokinetics and metabolism of eprinomectin in cats
when administered in a novel topical combination of fipronil, (S)-
methoprene, eprinomectin and praziquantel. Vet. Parasitol. 202,
2–9.
Ładczuk, D., Balicka-Ramisz, A., 2010. Wyste˛powanie pasoz˙ytów prze-
wodu pokarmowego u kotów z terenu miasta Szczecina. Wiad.
Parazytol. 56, 235–242.
Lucio-Forster, A., Bowman, D.D., 2011. Prevalence of fecal-borne parasites
detected by centrifugal flotation in feline samples from two shelters
in upstate New York. J. Feline Med. Surg. 13, 300–303.
Mircean, V., Titilincu, A., Cozma, V., 2010. Prevalence of endoparasites in
household cat (Felis catus) populations from Transylvania (Romania)
and association with risk factors. Vet. Parasitol. 171, 163–166.
Miró, G., Montoya, A., Jiménez, S., Frisuelos, C., Mateo, M.,  Fuentes, I., 2004.
Prevalence of antibodies to Toxoplasma gondii and intestinal para-
sites in stray, farm and household cats in Spain. Vet. Parasitol. 126,
249–255.
Mugnaini, L., Papini, R., Gorini, G., Passantino, A., Merildi, V., Mancianti,
F., 2012. Pattern and predictive factors of endoparasitism in cats in
Central Italy. Rev. Méd. Vét. 163, 89–94.
Näreaho, A., Puomio, J., Saarinen, K., Jokelainen, P., Juselius, T., Sutura,
A., 2012. Feline intestinal parasites in Finland: prevalence, risk fac-
tors and anthelmintic treatment practices. J. Feline Med. Surg. 14,
378–383.
Oakley, G.A., 1991. Anthelmintics for cats and dogs. Anpar, Berkhamsted,
Hertfordshire, UK.
Palmer, C.S., Thompson, R.C.A., Traub, R.J., Rees, R., Robertson, I.D., 2008.
National study of the gastrointestinal parasites of dogs and cats in
Australia. Vet. Parasitol. 151, 181–190.
Porqueddu, M.,  Scala, A., Tilocca, V., 2004. Principal endoparasitoses of
domestic cats in Sardinia. Vet. Res. Commun. 28, 311–313.
Prullage, J., Knaus, M., Bowman, D.D., Chester, S.T., Visser, M.,  Rehbein, S.,
Rosentel, J., 2014. Efficacy of a novel topical combination of fipronil,
(S)-methoprene, eprinomectin and praziquantel against induced
infections of Ancylostoma spp. nematodes of cats. Vet. Parasitol. 202,
30–33.
Rehbein, S., Capári, B., Duscher, G., Keidane, D., Kirkova, Z., Petkevicˇius, S.,
Rapti, D., Wagner, A., Wagner, T., Chester, S.T., Rosentel, J., Tielemans,
E., Visser, M.,  Winter, R., Kley, K., Knaus, M.,  2014. Efficacy against
nematode and cestode infections and safety of a novel topical fipronil,
(S)-methoprene, eprinomectin and praziquantel combination product
in domestic cats under field conditions in Europe. Vet. Parasitol. 202,
10–17.
Rehbein, S., Visser, M., Kellermann, M.,  Letendre, L., 2012. Reevaluation of
efficacy against nematode parasites and pharmacokinetics of topical
eprinomectin in cattle. Parasitol. Res. 111, 1343–1347.
Robben, S.R.M., Le Nobel, W.E., Döpfer, D., Hendrikx, W.M.L., Fransen, F.,
Eysker, M.E., 2004. Infecties met  helminthen en/of protozoën bij kat-
ten in asielen in Nederland. Tijdschr. Diergeneesk. 129, 2–6.
Rommel, M.,  Grelck, H., Hörchner, F., 1976. Zur Wirksamkeit von Prazi-
quantel gegen Bandwürmer in experimentell infizierten Hunden und
Katzen. Berl. Münch. Tierärztl. Wochenschr. 89, 255–257.
Schuster, R., Montag, A., 2000. Joyeuxiella pasqualei – ein ungewöhnlicher
Bandwurm bei einer einheimischen Hauskatze. Kleintierpraxis 45,
867–870.
Schuster, R.K., Thomas, K., Sivakumar, S., O’Donovan, D., 2009. The par-
asite fauna of stray domestic cats (Felis catus) in Dubai, United Arab
Emirates. Parasitol. Res. 105, 125–134.
y Parasi
S
S
T
TM. Knaus et al. / Veterinar
hoop, W.,  Soll, M.,  2002. Ivermectin, abamectin and eprinomectin. In:
Vercruysse, J., Rew, R. (Eds.), Macrocyclic Lactones in Antiparasitic
Therapy. CABI Publishing, Oxon, UK, pp. 1–29.
toichev, I., Janchev, J., Svilenov, D., 1982. Helminths and pathomorpho-
logical lesions in cats from villages of Bulgaria with human endemic
nephropathy. Zentralbl. Vet. Med. B 29, 292–302.
akács, A., Takács, P., 2002. Adatok a magyarországi vadászterületeken élo˝
házimacska (Felis catus domesticus) féregto˝zöttségéro˝l. Magyar Álla-
torvosok Lapja 124, 26–30.
ielemans, E., Manavella, C., Visser, M.,  Chester, S.T., Rosentel, J., 2014. Effi-
cacy in cats of a novel topical combination of fipronil, (S)-methoprene,
eprinomectin, praziquantel, against induced infestations of Echinococ-
cus multilocularis. Vet. Parasitol. 202, 26–29.tology 202 (2014) 18–25 25
Vercruysse, J., Holdsworth, P., Letonja, T., Barth, D., Conder, G.,
Hamamoto, K., Okano, K., 2001. International harmonisa-
tion of Anthelmintic Efficacy Guidelines. Vet. Parasitol. 96,
171–193.
Vercruysse, J., Holdsworth, P., Letonja, T., Conder, G., Hamamoto,
K., Okano, K., Rehbein, S., 2002. International harmonisation of
Anthelmintic Efficacy Guidelines (Part 2). Vet. Parasitol. 103,
277–297.Waap, H., Gomes, J., Nunes, T., 2013. Parasite communities in
stray cats from Lisbon, Portugal. J. Helminthol., http://dx.doi.org/
10.1017/S0022149X1300031X.
Wilson-Hanson, S.L., Prescott, C.W., 1982. A survey for parasites in cats.
Aust. Vet. J. 59, 194.
